Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

BACKGROUND: Preapproval trials showed that messenger RNA (mRNA)–based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile, yet these trials were subject to size and patient-mix limitations. An evaluation of the safety of the BNT162b2 mRNA vaccine w...

Descripción completa

Detalles Bibliográficos
Autores principales: Barda, Noam, Dagan, Noa, Ben-Shlomo, Yatir, Kepten, Eldad, Waxman, Jacob, Ohana, Reut, Hernán, Miguel A., Lipsitch, Marc, Kohane, Isaac, Netzer, Doron, Reis, Ben Y., Balicer, Ran D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427535/
https://www.ncbi.nlm.nih.gov/pubmed/34432976
http://dx.doi.org/10.1056/NEJMoa2110475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427535/
https://www.ncbi.nlm.nih.gov/pubmed/34432976
http://dx.doi.org/10.1056/NEJMoa2110475

Ejemplares similares